금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
TSMC profits surge amid relentless AI demand
World’s leading contract chipmaker beats estimates in third quarter...
British Pound holds gains as UK GDP and Industrial Production beat expectations
The British Pound (GBP) holds gains against the US Dollar (USD) on Wednesday’s early London session,...
UK economy "ekes out" 0.1% growth but outlook remains "challenging"
Monthly GDP unexpectedly grew by 0.1% in August 2026, following an unrevised growth of 0.4% in July ...
IXJ vs XPH: Global Healthcare ETF or Pharma Focus?
XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.
3 Small-Cap Stocks We Keep Off Our Radar
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small becau ...
Glencore, Mercuria pursuing Venezuela aluminum smelter deal - Bloomberg
Apollo in talks to acquire J&J’s orthopedics unit - Bloomberg
Review & Preview: Time to Hike
Here’s why major indexes actually rose on Friday despite the higher likelihood of a Fed interest rate increase.
Saudi shuts pipeline that was vital Hormuz bypass as new front opens in Middle East war
S&P 500, Dow Break Past Four-Day Loss To End Higher As Investors Eye Fed Meeting Next Week — DELL, HPE, EL, WMT In Focus
The consumer price index rose 0.4% in August, month over month and 3.4% year over year.
Larry Ellison to sell up to $7.5bn worth of Oracle stock
Founder to offload as many as 50mn shares as company posts higher revenue from data centres but faces investor fears it is overcommitted to AI
3 Tech Stocks Grew Their Dividends Up to 212% in 5 Years Without Breaking a Sweat
Three S&P 500 tech stocks combine strong five-year dividend growth, sub-50% payout ratios, and potential upside.
Novartis: More Pain on the Way?
Can it get any worse for Novartis’ U.S. stock? The Swiss company said Tuesday that del-desiran, part of a recent acquisition, reached the end of the line in a trial for a rare neuromuscular disease ...
Olema drops after hours on AstraZeneca Etcamah data
1 S&P 500 Stock with Impressive Fundamentals and 2 We Ignore
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some a ...